ST Phi Therapeutics
Seattle, US · Founded 2017
Biotech
Founders & leadership
LL
Lingfeng LiuExecutive Officer, Director
XG
Xiaobin GuoExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$500KraisedJan 2018 · 1 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.